Compound ID | 1209

Update compound information

CSE-1034

Class: Beta-lactam

Spectrum of activity: Gram-negative
Details of activity: Inhibitor of Cell wall synthesis; Gram-negative bacteria including MBLs
Combined with other compounds: yes
Institute where first reported: Venus Medicine Research Centre
Year first mentioned: 2004
Highest developmental phase: Phase 3 (Clinical Trial)
Development status: Active
External links:
Citations:
  • https://clinicaltrials.gov/ct2/show/NCT03477422
  • https://www.nature.com/articles/ja201282
  • http://www.venusremedies.com/asmconference
  • www.venusremedies.com/elores
    		•

    AntibioticDB is supported by GARDP.

    If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

    The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.